Publications:137
Hillel T Grossman, MD
About Me
Dr. Hillel Grossman is Co-Director of the Clinical Research Core of the Alzheimer's Disease Research Center and Clinical Director of the Mount Sinai Memory and Aging Center. Dr. Grossman is a psychiatrist by training with a focus in geriatric neuropsychiatry and has been involved in designing and conducting clinical studies in Alzheimer's disease. His studies are both observational, e.g. what happens as Alzheimer's progresses and interventional e.g. clinical trials. At present he is the Principal Investigator or Co-Principal investigator on numerous studies of potential treatments or diagnostic tools for Alzheimer's disease. Dr. Grossman has received funding from the NIH, VA and foundations for his investigations of interaction between Alzheimer's and Type II diabetes mellitus and the potential use of a natural insulin sensitizer, NIC5-15, in Alzheimer's disease. Dr. Grossman has also conducted work in the relationship late life depression and cognitive performance in HIV-1 infection.
Language
English
Position
ASSOCIATE PROFESSOR | Psychiatry
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Publications
Selected Publications
- Genetic modifiers of APOE-ε4-associated cognitive decline. Alex G. Contreras, Skylar Walters, Jaclyn M. Eissman, Derek B. Archer, Alexandra N. Regelson, Alaina Durant, Michelle Clifton, Subhabrata Mukherjee, Michael L. Lee, Seo Eun Choi, Phoebe Scollard, Emily H. Trittschuh, Jesse Mez, William S. Bush, Brian W. Kunkle, Carlos Cruchaga, Adam C. Naj, Katherine A. Gifford, Murat Bilgel, Amanda B. Kuzma, Balebail Ashok Raj, Kristin Fargher, Amanda Smith, Lisa Raudin, Gloria Chaing, Norman Relkin, Karen Elizabeth Smith, Hyungsub Shim, Laura L.Boles Ponto, Susan K. Schultz, Antero Sarrael, Raymundo Hernando, Nunzio Pomara, Dick Drost, Irina Rachinsky, Stephen Pasternak, Elizabether Finger, David Bachman, Kenneth Spicer, Hillel Grossman, Mary Sano, Brian Fulton-Howard, Alison M. Goate, Joseph D. Buxbaum, Ricardo Vialle, Andrew Sharp, Alan Renton, Towfique Raj, Jack Humphrey, Shea Andrews. Nature Communications
- Assessing subcortical, brainstem and cerebellar metabolic patterns using [18F]FDG PET-CT imaging in dementia with Lewy bodies. Daniël S.L. Loewenstein, Max van Grinsven, Cécile de Pont, Anne I.J. Arens, Paul L.J. Dautzenberg, Astrid M. van Strien, Osama Sabri, Swen Hesse, Michael Rullmann, Dylan Henssen, Kenneth Spicer, Crystal Flynn Longmire, Jacobo Mintzer, Yaneicy Gonazalez Rojas, V. Sotelo, William Hu, Floyd Jones, Amy Saklad, Sudha Seshadri, Amy Boegel, Sydni Jenee Hill, Paul Newhouse, Rebecca Long, Campbell Long, Arthur Williams, Allison Acree, Olga Brawman-Mintzer, Chelsea Reichert, Vita Pomara, Raymundo Hernando, Nunzio Pomara, Skieff Acothley, Nadeen Elayan, Micah Ellis Slaughter, Angelica Garcia, Marwan Sabbagh, Maushami Gurung, Richard Le, Joseph Masdeu, Christina Rosario, Caroline Smith, Teresa Kalowsky, Edgardo Rivera, Hamid Okhravi, Rebecca Devine, Nasrin Ghesani, Mary Sano, Laili Soleimani, Judith Neugroschl, Hillel Grossman. European Journal of Nuclear Medicine and Molecular Imaging
- GWAS of Tau-Neurodegeneration Mismatch Identifies New Risk Loci for Susceptibility to Tau. Fardin Nabizadeh, Hanieh Mohamadi, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowski, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Zaven Khachaturian, Greg Sorensen, Lew Kuller, Marcus Raichle, Steven Paul, Peter Davies, Howard Fillit, Franz Hefti, David Holtzman, Marek M. Mesulam, William Potter, Peter Snyder, Adam Schwartz, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein, Paul Thompson, Norbert Schuff, Bret Borowski, Jeff Gunter, Matt Senjem, Prashanthi Vemuri, David Jones, Kejal Kantarci, Chad Ward, Robert A. Koeppe, Norm Foster, Eric M. Reiman, Kewei Chen, Hillel Grossman. CNS Neuroscience and Therapeutics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Grossman has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.